Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Total Current Liabilities (2017 - 2026)

Updated

Grace Therapeutics' Total Current Liabilities was $1.25 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 46.0% from $2.32 million a year earlier and down 41.8% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Total Current Liabilities at Grace Therapeutics came in at $2.15 million, up 11.2% from FY2025.

  • Total Current Liabilities shows a five-year compound annual growth rate of 6.3% (FY2021 to FY2026).
  • In earlier fiscal years, Total Current Liabilities was $1.93 million in FY2025 (+14.6%), $1.68 million in FY2024 (-50.6%), $3.41 million in FY2023 (+4.6%) and $3.26 million in FY2022 (+106.5%).
  • Quarterly Total Current Liabilities has moved between $1.25 million (fiscal Q2 2026) and $4.48 million (fiscal Q2 2022) over five years.
  • Compared with a year earlier, Total Current Liabilities was higher in four of the last eight quarters, with an average decline of 2.1%.
  • The best year-over-year quarter for Total Current Liabilities over five years was fiscal Q4 2022 (growth of 106.5%); the worst was fiscal Q2 2024 (a decline of 63.3%).
  • Per Business Quant data, GRCE's Total Current Liabilities in the three fiscal quarters before Q1 2027 was $2.15 million (Q4 2026), $1.28 million (Q3 2026) and $1.25 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Grace Therapeutics 34.02 Mn -32.25 Mn - 1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Mn
Mar 31, 2026 2.15 Mn
Dec 31, 2025 1.28 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 2.32 Mn
Mar 31, 2025 1.93 Mn
Dec 31, 2024 1.97 Mn
Sep 30, 2024 2.67 Mn
Jun 30, 2024 2.60 Mn
Mar 31, 2024 1.68 Mn
Dec 31, 2023 1.77 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.97 Mn
Mar 31, 2023 3.41 Mn
Dec 31, 2022 3.43 Mn
Sep 30, 2022 3.81 Mn
Jun 30, 2022 3.71 Mn
Mar 31, 2022 3.26 Mn
Dec 31, 2021 2.90 Mn
Sep 30, 2021 4.48 Mn
API Access

Grace Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEY